Otani Masako, Zhang Lianshan, Aoyagi Daiju, Chowdury Rownak, Shigematsu Hidekazu
Department of Pathology, Shinshu University School of Medicine, Matsumoto, Japan.
J Nephrol. 2006 Jul-Aug;19(4):449-57.
The relationship between mesangial cell proliferation and sclerosis has been studied using rat Thy-1.1 nephritis. The reconstruction of capillary lumina is essential for the repair of postinflammatory tissue damage in this type of glomerulonephritis.
We administered thalidomide or STI571 to Thy-1.1 nephritic rats. Thalidomide was intended to be a sup-pressor of capillary proliferation, and STI571, which is known to be a tyrosine kinase receptor inhibitor, was used for preventing mesangial proliferation.
The thalidomide-treated group showed a significant increase of urinary protein on day 3. ED-1-positive cells stagnated longer and the matrix increase was delayed. STI571 caused suppression of mesangial proliferation, and microaneurysm remained longer than in the other 2 groups, which resulted in delay of glomerular capillary reconstruction. The number of alfa-SMA-positive cells appeared to be smaller in both the thalidomide- and the STI571-treated groups.
Thalidomide had an effect in the early period of the experiment; however, there was no influence on the repair of glomerular capillary at the end. STI571 treatment, which inhibited proliferation of alfa-SMA-positive cells, seems to show that some degree of mesangial cell proliferation is necessary to reconstruct capillary structures and to regain glomerular function.
利用大鼠Thy-1.1肾炎模型研究了系膜细胞增殖与硬化之间的关系。在这类肾小球肾炎中,毛细血管腔的重建对于炎症后组织损伤的修复至关重要。
我们给Thy-1.1肾炎大鼠施用沙利度胺或STI571。沙利度胺旨在抑制毛细血管增殖,而STI571作为一种已知的酪氨酸激酶受体抑制剂,用于预防系膜增殖。
沙利度胺治疗组在第3天尿蛋白显著增加。ED-1阳性细胞停滞时间更长,基质增加延迟。STI571导致系膜增殖受到抑制,微动脉瘤持续时间比其他两组更长,导致肾小球毛细血管重建延迟。在沙利度胺和STI571治疗组中,α-SMA阳性细胞数量似乎较少。
沙利度胺在实验早期有作用;然而,最终对肾小球毛细血管的修复没有影响。抑制α-SMA阳性细胞增殖的STI571治疗似乎表明,一定程度的系膜细胞增殖对于重建毛细血管结构和恢复肾小球功能是必要的。